LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Clinical trial NCT02205762 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02205762
- Sponsor
- North American Consortium for Histiocytosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-02
- Primary completion
- 2026-07-01
- Enrollment
- 1400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.